SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intels weak fourth-quarter outlook overshadowed its quarterly results, with soft PC demand and manufacturing constraints weighing on expectations and prompting analyst downgrades. Traders are divided between calling the selloff an overreaction and expecting further declines.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A sharp Nasdaq and technology-stock selloff, amid concerns about AI valuations, heavy infrastructure spending and disappointing tech earnings, is driving discussion; Intels plunge is a frequent focus. Traders are split between expecting further losses and viewing the decline as an oversold correction, while claims of forced liquidations and geopolitical or election-related triggers remain speculative.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisks sharp selloff despite beating earnings expectations, raising guidance and announcing a stock split dominates discussion, with traders pointing to broad tech and memory-stock weakness and fears that memory pricing and earnings growth may be nearing a cyclical peak. Many view the drop as an overreaction and are buying the dip, while others argue slowing growth and the memory cycle justify caution.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,105,365. The last known price of Bitcoin is 76,874.98691422 USD and is down -4.82 over the last 24 hours. It is currently trading on 12773 active market(s) with $58,826,736,014.03 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

A reported Binance security breach and temporary withdrawal suspension have fueled selling and fears of contagion across crypto, adding pressure to Bitcoin amid a broader risk-off move. Traders disagree on whether the incident signals deeper exchange risks and more downside or is a buying opportunity, noting that Bitcoin itself was not directly hacked.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit shares plunged after its quarterly report paired strong results with a softer revenue outlook, slowing user growth and warnings that declining Google search referrals could pressure traffic; plans to test a logged-in-first experience added concern about losing casual visitors. Traders debate whether the selloff is an overreaction to temporary headwinds or reflects a deeper threat to Reddits user growth and advertising model.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

A sharp semiconductor and tech selloff, led in part by Intels weak outlook and concerns about AI/PC demand, has hammered SOXLs 3x leveraged exposure. Traders are split between buying the dip for a relief bounce and warning that sector weakness and leverage-driven losses could deepen.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CRMD is drawing attention after a sharp selloff tied to DaVitas warning that DefenCaths post-TDAPA reimbursement contribution could fall significantly after Q1 2027, raising concerns about future adoption and revenue. Traders disagree over whether DaVitas preliminary estimate signals a real commercial risk or is outweighed by CMSs reimbursement outlook; some view the decline as an overreaction.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

IOVAs sharp selloff followed updated lifileucel lung-cancer trial data: the overall response rate was roughly in line with the prior update, while a retrospective biomarker-selected subgroup showed a much higher response rate, leaving investors debating the narrower opportunity, uncertain durability and FDA path. Traders also criticized managements presentation; some see the reaction as excessive and the precision-treatment strategy as promising, while others remain concerned about delayed validation and lost confidence in management.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

The move to a fresh 52-week high is centered on Q3 earnings expectations and continued BRIUMVI growth. Traders also speculate that buyout interest or short covering may be adding to momentum, though no acquisition is confirmed.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

DIA is under pressure amid a broad market selloff, with traders citing rising oil prices and escalating Middle East tensions alongside scrutiny of tech earnings and AI spending. The discussion is broadly bearish, though some traders point to market rotation and see pullbacks as buying opportunities.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is State Street SPDR S&P Health Care Services ETF (XHS) a Strong ETF Right Now?

Should You Invest in the State Street SPDR S&P Health Care Services ETF (XHS)?

Best ETF Areas of June

Biotech, China, insurance and healthcare ETFs led June gains as strong earnings, AI optimism and easing geopolitical fears lifted markets.

Health Care Services ETF (XHS) Touches a New 52-Week High

XHS hits a new 52-week high as healthcare-services stocks gain from steady earnings and defensive investor positioning.

Winners & Losers: The ETF Playbook to Glide Trump's Great Healthcare Plan

Trump's Great Healthcare Plan redraws healthcare winners and losers - here's how ETFs like IHE could benefit as middlemen face pressure.

The Zacks Analyst Blog Highlights LLY, EPHE, BBC, HELX, XHS and SURI

LLY, EPHE, BBC, HELX, XHS and SURI headline last week's top-performing ETFs as healthcare and biotech outperform a weak broader market.

Best-Performing ETFs of Last Week: Healthcare Rules

Healthcare and biotech led last week's winners, with EPHE, BBC, HELX, XHS and SURI topping ETF gains as markets slid on AI worries and Fed uncertainty.

How Is DaVita's Stock Performance Compared to Other Health Care Services Stocks?

DaVita has underperformed the health care services industry this year, and analysts are cautious about the stock’s prospects.

SPDR Series Trust - State Street SPDR S&P Health Care Services ETF

Cigna Stock Slips On More Price-Target Cuts After Weak Q4, But Retail Bets On A Rebound

Equity

Neutral Sentiment

Shares of The Cigna Group traded about 0.8% lower in volatile action Monday morning as Wall Street analysts continued to slash price targets following last week's disappointing fourth-quarter earnings miss.However, retail sentiment remained strong, indicating traders are betting on a rebound.According to The Fly, TD Cowen analyst Charles Rhyee lowered his price target on Cigna to $380 from $391 while maintaining a 'Buy' rating, citing continued upside from strong specialty trends despite the weak quarter.Piper Sandler analyst Jessica Tassan cut her price target to $348 from $394, keeping an 'Overweight' rating. The brokerage attributed Cigna's Q4 earnings miss to a rise in high-cost claimants within its Stop-Loss segment.<figure class="image"><img style="aspect-ratio:1318/324;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/CI_sentiment_and_message_volume_on_Feb_3_premarket_1c05b0067d.png" alt="CI sentiment and message volume on Feb 3 premarket.png" width="1318" height="324"><figcaption>CI sentiment and message volume on Feb 3 as of 10:30 am ET | source: Stocktwits</figcaption></figure>Despite the fresh price-target cuts, sentiment on Stocktwits remained 'extremely bullish,' suggesting retail investors have been buying the dip.Cigna shares have climbed more than 5% since last week's earnings report, with many retail traders arguing the stock is oversold and offers an attractive entry point.<stembedurl>https://stocktwits.com/Mackman15/message/602301602</stembedurl><stembedurl>https://stocktwits.com/healthcareguru/message/602261078</stembedurl>According to Koyfin data, the health insurer's stock trades 25% below analysts' average price target of $367.87. Shares are up 4.6% year-to-date.In a separate announcement Monday, Cigna said it will begin linking executive compensation to customer satisfaction, pledging to streamline access to care by making the process "simpler, easier, and faster."&nbsp;The company plans to implement governance changes to improve accountability and will publish an annual customer transparency report starting next year.The move comes weeks after UnitedHealth CEO Brian Thompson was shot and killed in New York City, reigniting debates over the state of U.S. health care.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Cigna Corporation logo is displayed on a monitor. (Photo Illustration by Valera Golovniov/SOPA Images/LightRocket via Getty Images)

Shares have climbed more than 5% since last week's earnings report, with many retail traders arguing the stock is oversold and offers an attractive entry point.

Cigna Corp.

iShares U.S. Healthcare Providers ETF

SPDR S&P Health Care Services ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$142.73
Prev Close	$144.36
Open	$144.41
Dividend Yield	N/A
50-Day Moving Average	$136.76
Beta	N/A
Avg. Volume	33,485.44
PE Ratio	N/A

52-Week High	$144.61
52-Week Low	$98.15
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

XHS Fundamentals